A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes

BACKGROUND: Dys-megakaryopoiesis is defined as ≥10 % of dysplastic megakaryocytes in bone marrow smears by the World Health Organization. However, concordance rates for dysplastic megakaryocytes between different observers is low and, consequently, evaluation of dysmegakaryopoiesis is also often dis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Hematol Oncol
Glavni autori: Feng, Gege, Gale, Robert Peter, Cui, Wen, Cai, Wenyu, Huang, Gang, Xu, Zefeng, Qin, Tiejun, Zhang, Yue, Li, Bing, Fang, Liwei, Zhang, Hongli, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Wang, Jingya, Cui, Yajuan, Xiao, Zhijian
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4848808/
https://ncbi.nlm.nih.gov/pubmed/27127725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0041-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items